You could be forgiven for thinking Invisalign has the market to itself. The brand name is almost generic now, a fixture in the cultural conversation about straightening teeth. Yet here at the financial desk, the picture for its parent company, Align Technology, is more complex. The market’s recent treatment of the stock tells you that. After a period of intense competition from at-home clear aligner startups, the pressure has eased. Some of those upstarts have stumbled or shifted strategies. You might expect Align to be thriving, its dominance reaffirmed. The reality is more nuanced, and it reveals a fundamental question about this company’s next chapter.
For years, Align’s primary battle was defending its castle. Companies like SmileDirectClub offered a direct-to-consumer model at a fraction of the cost. The fight was brutal and public, waged through marketing campaigns and courtroom filings. Align aggressively protected its intellectual property, filing lawsuits alleging patent infringement. The strategy yielded results. SmileDirectClub’s bankruptcy filing in late 2023 was a watershed moment, removing the most prominent low-cost challenger from the field.
Other competitors have scaled back their ambitions. Candid Co. pivoted to a hybrid model working more closely with dentists. Byte, owned by dental giant Dentsply Sirona, continues but without the market-shaking impact some feared. This competitive relief is real. You can see it in Align’s latest quarterly reports. The company reported 5.8% year-over-year growth in clear aligner volume for the fourth quarter of 2023. Revenue reached $956.7 million, beating analyst expectations. The stock, however, did not celebrate.
This disconnect points to the new challenge. The street is no longer focused solely on competitive threats. It is asking about Align’s own growth engine. With the most vocal disruptors quieted, where will sustainable, high-margin growth come from? The company’s guidance for the first quarter of 2024 was cautious, forecasting revenue between $960 million and $980 million. That implies growth but at a measured pace. Analysts are parsing every word. A note from investment bank Piper Sandler highlighted that while competitive fears have abated, “investor focus has shifted to Align’s ability to re-accelerate growth.”
This is the core of the 2025 outlook. Growth must now come from market expansion, not just market defense. Align’s playbook involves two main paths:
- Push deeper into the international market
- Focus on regions like China and Europe
- Build relationships with local dental professionals
- Adapt to different regulatory landscapes
- Enhance the digital ecosystem
- Integrate iTero scanner and software
Success there requires more than shipping product. The progress is tangible but slow. International revenue grew 9.3% year-over-year in Q4 2023, but it remains a smaller portion of the overall pie.
Second, the company is betting on its digital ecosystem. This is more than just the plastic aligners. It includes the iTero scanner, a tool that creates a digital impression of a patient’s mouth, and the proprietary software that plans the treatment. The goal is to lock dental professionals into an integrated Align workflow. When a practice uses an iTero scanner and Align’s software, switching to a competitor becomes more difficult. iTero scanner sales were a bright spot last quarter, with revenue jumping 21.7% year-over-year. This is a high-margin, recurring business that builds a moat around the core aligner sales.
The financial community is watching this transition closely. Data from the American Association of Orthodontists shows that while clear aligner case starts are growing, a significant portion of the adult population who desire treatment remains untapped. The potential is there. Yet converting that potential into reliable earnings requires flawless execution. Any misstep in international expansion or any slowdown in the adoption of its digital tools will be punished by the market. The stock’s sensitivity to guidance, as seen in recent quarterly reactions, proves this.
Looking ahead, the narrative for Align Technology in 2025 hinges on execution. The competitive clouds have parted, giving the company a clearer runway. Now it must prove it can take off under its own power. Investors are no longer paying for a story about beating back challengers. They are paying for a story of disciplined, profitable growth in new markets and through higher-value products. The next few quarters will be a critical test of whether the company can deliver that story. The path is set. The pressure is on.
| Quarter | Revenue ($ million) | Year-over-Year Growth (%) |
|---|---|---|
| Q4 2023 | 956.7 | 5.8 |
| Q1 2024 (forecast) | 960 – 980 | N/A |
| International Revenue Growth | N/A | 9.3 |
| iTero Scanner Revenue Growth | N/A | 21.7 |